Posted by Michael Wonder on 18 Aug 2022
Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes
18 August 2022 - Medicines Australia welcomes the restart of the National Medicines Policy Review, which was put on hold prior to the May Federal Election following calls from stakeholders who sought improved consultation.
Medicines Australia CEO, Elizabeth de Somer, said the restart of the Review showed the Government’s commitment for Australians to have equitable and affordable access to medicines.
